[Advances of heterogeneity of EGFR in non-small cell lung cancer]

Zhongguo Fei Ai Za Zhi. 2011 Nov;14(11):890-3. doi: 10.3779/j.issn.1009-3419.2011.11.11.

[Article in Chinese]

Authors

Hua Zheng¹, Hongmei Zhang, Heling Shi, Baolan Li

Affiliation

¹ General Department, Beijing Chest Hospital of Capital Medical University, Beijing 101149, China.

PMID: 22104226
PMCID: PMC5999990
DOI: 10.3779/j.issn.1009-3419.2011.11.11

No abstract available

Publication types

Review

MeSH terms

Antineoplastic Agents / therapeutic use
Carcinoma, Non-Small-Cell Lung / drug therapy
Carcinoma, Non-Small-Cell Lung / genetics*
Carcinoma, Non-Small-Cell Lung / metabolism
ErbB Receptors / genetics*
ErbB Receptors / metabolism
Genetic Variation
Humans
Lung Neoplasms / drug therapy
Lung Neoplasms / genetics*
Lung Neoplasms / metabolism
Mutation

Substances

Antineoplastic Agents
EGFR protein, human
ErbB Receptors